DigiCert S/MIME Class 2 Certificate Benefits
- Email encryption. This DigiCert S/MIME certificate digitally signs your emails and enables end-to-end encryption between you and your recipients. Once you hit the “send” button, you’ll have peace of mind that no attacker will intercept your confidential messages. Breaking the 256-bit encryption and a 2048-bit signature key is beyond human capabilities.
- Document signing. This certificate can also secure Microsoft® Office, OpenOffice business documents, and emails. It will also ease the transition from ink paperwork to digital workflows. Applying the digital signature to a document will ensure its authenticity and prevent hackers from altering it.
- User two-factor authentication. The Digicert S/MIME Class 2 certificate is used for two-factor authentication. Once a server is configured for client certificate authentication, it will only grant a user access if the client presents the correct client certificate. When using a web browser to connect to the server, the client cannot access the credentials page without the proper client certificate.
- FDA ESG compliant. If you’re doing business with the FDA (Food and Drug Administration), encrypting your emails is required. The ESG (Electronic Submission Gateways) verifies the senders’ identity before sending your email to the relevant FDA office. This email certificate ensures smooth and secure communication with the FDA.
- Domain control, identity verification, and organization validation. This email certificate offers the highest level of validation for emails and digital documents. After validation, your company address and name will appear in the certificate fields along with your first and last names.
- Compatible with almost any platform. It is fully trusted by all major servers, email clients, and Internet browsers. You can install them on Windows, Linux, Mac, and many other platforms. They also support major email servers such as Netscape Communicator, Microsoft Outlook, Microsoft Exchange, and Mozilla Thunderbird.
